Shimizu Takashi, Hayashi Masachika, Shimizu Natsue, Kinebuchi Shin-ichi, Toyama Jozi
Department of Internal Medicine, Joetsu General Hospital.
Nihon Kokyuki Gakkai Zasshi. 2009 Jun;47(6):543-7.
We reported a case of drug-induced lung injury associated with mesalazine. A 50-year-old woman was diagnosed as having ulcerative colitis and treated with mesalazine. After administration for 1 month, the patient developed dry cough, fever and bilateral pulmonary infiltrates. A bronchoalveolar lavage showed 6.5 x 10(5) cells/ml, with 58% lymphocytes and 20% eosinophils. Improvement in clinical symptoms and radiological abnormalities occurred spontaneously after discontinuation of mesalazine. Even though the signs and symptoms of mesalazine-induced lung injury are similar to those of the pulmonary involvement of inflammatory bowel disease, it is important to distinguish them differences.
我们报告了一例与美沙拉嗪相关的药物性肺损伤病例。一名50岁女性被诊断为溃疡性结肠炎,并接受美沙拉嗪治疗。用药1个月后,患者出现干咳、发热和双侧肺部浸润。支气管肺泡灌洗显示每毫升有6.5×10⁵个细胞,其中淋巴细胞占58%,嗜酸性粒细胞占20%。停用美沙拉嗪后,临床症状和影像学异常自发改善。尽管美沙拉嗪所致肺损伤的体征和症状与炎症性肠病肺部受累的体征和症状相似,但区分它们的差异很重要。